Rb Capital Management, LLC Akebia Therapeutics, Inc. Transaction History
Rb Capital Management, LLC
- $416 Million
- Q4 2024
A detailed history of Rb Capital Management, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Rb Capital Management, LLC holds 10,000 shares of AKBA stock, worth $18,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$18,200
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AKBA
# of Institutions
128Shares Held
63.3MCall Options Held
50.6KPut Options Held
203K-
Black Rock Inc. New York, NY11.6MShares$21.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$19.8 Million0.0% of portfolio
-
State Street Corp Boston, MA6.3MShares$11.5 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$10.5 Million20.26% of portfolio
-
Geode Capital Management, LLC Boston, MA4.8MShares$8.73 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $335M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...